-
Oct 16, 2024 | 
bluesrockreview.com | Jeff S. Healey |Fidel Beserra
Blues rock is a genre that has carved its own distinct place in music, known for its powerful combination of emotional intensity and electrifying displays of virtuosism. It has given rise to some of the most iconic guitar solos in modern music, where technical mastery and emotional expression come together to create magic. In this article, we explore ten of the most iconic guitar solos in blues rock, performed by legendary musicians whose influence remains central to the genre.
-
Sep 27, 2024 | 
blog.cloudera.com | Jeff S. Healey
Cloudera customers understand the potential impact of data, analytics, and AI on their respective businesses — reducing costs, managing risk, improving customer satisfaction, and generating new business opportunities that help to increase market share. But, what is the ultimate impact of all this effort and investment on each of us in our daily lives?
-
Aug 21, 2024 | 
blog.cloudera.com | Jeff S. Healey
The CRN Tech Innovator Awards spotlight innovative products and services across 36 categories, with winners chosen by CRN staff from over 320 product applications. This year, we’re excited to share that Cloudera’s Open Data Lakehouse 7.1.9 release was named a finalist under the category of Business Intelligence and Data Analytics. These awards, held annually, are intended to help solution providers identify IT products and services that are truly innovative and deliver customer value.
-
Aug 20, 2024 | 
blog.cloudera.com | Jeff S. Healey
By now, every organization, regardless of industry, has at least explored the use of AI, if not already embraced it. In today’s market, the AI imperative is firmly here, and failing to act quickly could mean getting left behind. But even as adoption soars, struggles remain, and scalability continues to be a major issue. Organizations are quick to adopt AI, but getting it established across the organization brings a unique set of challenges that come into play.
-
Aug 1, 2024 | 
blog.cloudera.com | Jeff S. Healey
Enterprise IT leaders across industries are tasked with preparing their organizations for the technologies of the future – which is no simple task. With the use of AI exploding, Cloudera, in partnership with Researchscape, surveyed 600 IT leaders who work at companies with over 1,000 employees in the U.S., EMEA and APAC regions.
-
Jun 13, 2024 | 
blog.cloudera.com | Jeff S. Healey
Hadoop. The first time that I really became familiar with this term was at Hadoop World in New York City some ten or so years ago. There were thousands of attendees at the event – lining up for book signings and meetings with recruiters to fill the endless job openings for developers experienced with MapReduce and managing Big Data. This was the gold rush of the 21st century, except the gold was data.
-
Jan 25, 2024 | 00073-4/abstract&sz=64)
onlinecjc.ca | Jeff S. Healey |Jorge A. Wong
1 Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Since their introduction as therapeutic devices to treat patients with cardiac arrhythmias, implanted pacemakers and defibrillators have evolved into long-term, continuous diagnostic devices which have greatly expanded our understanding of heart rhythm disorders and their associated prognosis.
-
Nov 20, 2023 | 
medscape.com | John Mandrola |Jeff S. Healey
Recorded November 12, 2023. This transcript has been edited for clarity. John M. Mandrola, MD: Hi everyone. This is John Mandrola from theheart.org | Medscape Cardiology. I'm here at the American Heart Association meeting in Philadelphia, and I'm excited to have Professor Jeff Healey from McMaster University, who was a primary investigator of the ARTESIA trial.
-
Nov 17, 2023 | 
radcliffecardiology.com | Harriette Van Spall |Jeff S. Healey |Michelle L. O'Donoghue |Steven Nissen
AHA 2023 — Investigator, Dr Steven E Nissen (Cleveland Clinic, US) is interviewed by CardioNerds Medical Education Fellow, Dr Maryam Barkhordarian (HMH Palisades Medical Center, US) on the trial that assessed the efficacy and safety of lepodisiran, a small interfering RNA (NCT05565742). The main purpose of this phase 2, randomised, double-blind, placebo-controlled study (Eli Lilly and Company) is to investigate the efficacy and safety of LY3819469 in adults with elevated lipoprotein(a).
-
Nov 12, 2023 | 
healio.com | Erik Swain |Richard Smith |Jeff S. Healey |Christine M Albert
You've successfully added Cardiology: Arrhythmia Disorders to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: In patients with subclinical atrial fibrillation, apixaban lowered risk for stroke and systemic embolism vs. aspirin.
